Showing results (1-10 of 83) with videos related to
Sort By:
Pageof 9
Clinical Pharmacology and Therapeutics|February 1, 1985
Intravenous nizatidine kinetics and acid suppressionJ T Callaghan, R F Bergstrom, B D Obermeyer, et al.Clinical Pharmacology and Therapeutics|April 1, 1990
Relationship between steady-state plasma nizatidine concentrations and inhibition of basal and stimulated gastric acid secretionD W Schneck, J T Callaghan, R F Bergstrom, et al.Clinical Pharmacology and Therapeutics|November 1, 1987
Absorption studies of the H2-blocker nizatidineM P Knadler, R F Bergstrom, J T Callaghan, et al.Clinical Pharmacology and Therapeutics|June 1, 1990
Secretion of nizatidine into human breast milk after single and multiple dosesB D Obermeyer, R F Bergstrom, J T Callaghan, et al.Scandinavian Journal of Gastroenterology. Supplement|January 1, 1987
A pharmacokinetic profile of nizatidine in manJ T Callaghan, R F Bergstrom, A Rubin, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1986
Nizatidine, an H2-blocker. Its metabolism and disposition in manM P Knadler, R F Bergstrom, J T Callaghan, et al.Journal of Clinical Pharmacology|August 1, 1987
Nizatidine, and H2-receptor antagonist: disposition and safety in the elderlyJ T Callaghan, A Rubin, M P Knadler, et al.Clinical Pharmacokinetics|October 8, 1999
Olanzapine. Pharmacokinetic and pharmacodynamic profileJ T Callaghan, R F Bergstrom, L R Ptak, et al.Clinical Pharmacology and Therapeutics|June 1, 1988
Nizatidine disposition in subjects with normal and impaired renal functionG R Aronoff, R F Bergstrom, R J Bopp, et al.Pharmacotherapy|December 17, 1998
Lack of effect of olanzapine on the pharmacokinetics of a single aminophylline dose in healthy menW L Macias, R F Bergstrom, B J Cerimele, et al.Pageof 9